NYSE · FLMNY
Healthcare · Medical - Instruments & Supplies
$9.52
Up+$0.00 (+0.00%)
Updated Nov 15, 2026, 2:32 AM
SID Score
5.2/10
Composite research score
Smart Money
46/100
Neutral
Price performance · FLMNY
1M range · 0 trading sessions · Daily adjusted prices
FLMNY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning FLMNY.
Company
Market Activity
Research & News
FLMNY research
Company profile and research snapshot.
FIELMANN GROUP AG U/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2026 | BERENBERG | Buy | — |
| Aug 28, 2026 | STIFEL EUROPE | Buy | — |
| Aug 27, 2026 | MWB RESEARCH AG | Buy | — |
| Aug 21, 2026 | BAADER HELVEA EQUITY RESEARCH | Buy | — |
| Jul 14, 2026 | BERENBERG | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 8, 2026
Fielmann Group AG (FLMNF) posted broad-based Q3 growth, opened 56 net new stores year-to-date, and reaffirmed full-year targets despite a slow US transformation and EUR15 million in price cuts.
SeekingAlpha · Nov 7, 2026
2026-11-07. The following slide deck was published by Fielmann Group AG in conjunction with their 2026 Q3 earnings call.
SeekingAlpha · Nov 5, 2026
Fielmann Group AG (FLMNY) Q3 2026 Earnings Call November 5, 2026 9:00 AM ESTCompany ParticipantsSteffen Baetjer - CFO, Head of Finance, Controlling, Legal...
Yahoo · Oct 18, 2026
Fielmann Group shares closed at €38.30, and after several difficult years for the stock, investors are increasingly asking whether that price is properly supported by the optician group’s earnings power. With sentiment shaped more by a long stretch of weak returns rather than by headlines, the valuation question has shifted firmly to what the current profit stream really justifies. Over the past 5 years the share price has fallen 23.6%, which puts the spotlight on whether the current...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning FLMNY.
